The Association of Plasma Resistin with Dietary Sodium Manipulation, the Renin-angiotensin-aldosterone System, and 25-hydroxyvitamin D3 in Human Hypertension

Overview

Journal Clin Endocrinol (Oxf)

Specialty Endocrinology

Date 2010 Nov 6

PMID 21050256

Citations 16

Authors

Anand Vaidya

Luminita Pojoga

Patricia C Underwood

John P Forman

Paul N Hopkins

Gordon H Williams

Jonathan S Williams

Affiliations

Soon will be listed here.

Abstract

Objective: Both resistin and vitamin D have been associated with the renin-angiotensin-aldosterone system (RAAS). We investigated the association between resistin and the RAAS, and resistin and vitamin D under controlled dietary sodium conditions.

Design: Retrospective cross-sectional study of subjects from the HyperPATH Consortium, who were maintained in high dietary sodium (HS) and low dietary sodium (LS) balance for 1 week each.

Patients: Caucasian subjects with hypertension (n=177).

Measurements: 25-Hydroxyvitamin D (25[OH]D) levels were used to assess vitamin D status. Plasma resistin and RAAS measures were evaluated on each dietary intervention.

Results: Resistin levels were significantly higher in LS, where RAAS activity was high, when compared with HS balance, where RAAS activity was suppressed (6.36 vs 5.86 μg/l, P < 0.0001); however, resistin concentrations were not associated with plasma renin activity or serum aldosterone on either diet. 25(OH)D levels were positively and independently associated with resistin in both dietary conditions (HS: β=0.400, P-trend=0.027; LS: β=0.540, P-trend=0.014).

Conclusions: Dietary sodium loading reduced resistin levels, possibly by suppressing the RAAS; however, circulating RAAS components were not related to resistin concentrations within each specific dietary sodium condition. 25(OH)D was positively associated with resistin and may be involved in resistin regulation through an unknown mechanism. Further studies to understand resistin regulation in human hypertension better are warranted.

Citing Articles

Physical Activity and the Acute Hemodynamic Response to ACE Inhibition in Hypertension.

Maris S, Meyer K, Murray G, Williams J Am J Lifestyle Med. 2022; 16(4):538-545.

PMID: 35860373 PMC: 9290176. DOI: 10.1177/1559827620935367.

The Association between Serum Resistin Level, Resistin (-420C/G) Single Nucleotide Variant, and Markers of Endothelial Dysfunction, including Salt Taste Preference in Hypertensive Patients.

Musialik K, Miller-Kasprzak E, Walczak M, Markuszewski L, Bogdanski P Nutrients. 2022; 14(9).

PMID: 35565757 PMC: 9102533. DOI: 10.3390/nu14091789.

Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health.

Tariq S, Tariq S, Khaliq S, Baig M, Murad M, Lone K Front Endocrinol (Lausanne). 2021; 11:615440.

PMID: 33519717 PMC: 7844394. DOI: 10.3389/fendo.2020.615440.

Serum vitamin D and diabetic foot complications.

Greenhagen R, Frykberg R, Wukich D Diabet Foot Ankle. 2019; 10(1):1579631.

PMID: 30815231 PMC: 6383621. DOI: 10.1080/2000625X.2019.1579631.

Vitamin D supplementation increases adipokine concentrations in overweight or obese adults.

Mousa A, Naderpoor N, Wilson K, Plebanski M, de Courten M, Scragg R Eur J Nutr. 2019; 59(1):195-204.

PMID: 30649593 DOI: 10.1007/s00394-019-01899-5.

References

Heilbronn L, Rood J, Janderova L, Albu J, Kelley D, Ravussin E . Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab. 2004; 89(4):1844-8. DOI: 10.1210/jc.2003-031410. View

Fain J, Cheema P, Bahouth S, Hiler M . Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003; 300(3):674-8. DOI: 10.1016/s0006-291x(02)02864-4. View

Androulakis E, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C . Essential hypertension: is there a role for inflammatory mechanisms?. Cardiol Rev. 2009; 17(5):216-21. DOI: 10.1097/CRD.0b013e3181b18e03. View

Nagaev I, Smith U . Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001; 285(2):561-4. DOI: 10.1006/bbrc.2001.5173. View

Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M . Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension. 2008; 51(2):534-9. DOI: 10.1161/HYPERTENSIONAHA.107.103077. View

Lee J, Chan J, Yiannakouris N, Kontogianni M, Estrada E, Seip R . Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003; 88(10):4848-56. DOI: 10.1210/jc.2003-030519. View

Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm B . Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010; 411(17-18):1354-60. DOI: 10.1016/j.cca.2010.05.037. View

Gannage-Yared M, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G . Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009; 160(6):965-71. DOI: 10.1530/EJE-08-0952. View

Price D, Fisher N . The renin-angiotensin system in blacks: active, passive, or what?. Curr Hypertens Rep. 2003; 5(3):225-30. DOI: 10.1007/s11906-003-0025-x. View

10.

Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B . The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine. 2009; 36(2):205-10. DOI: 10.1007/s12020-009-9216-9. View

11.

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

12.

Lely A, Krikken J, Bakker S, Boomsma F, Dullaart R, Wolffenbuttel B . Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab. 2007; 92(5):1821-6. DOI: 10.1210/jc.2006-2092. View

13.

Thomopoulos C, Daskalaki M, Papazachou O, Rodolakis N, Bratsas A, Papadopoulos D . Association of resistin and adiponectin with different clinical blood pressure phenotypes. J Hum Hypertens. 2010; 25(1):38-46. DOI: 10.1038/jhh.2010.22. View

14.

Resnick L, Muller F, LARAGH J . Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986; 105(5):649-54. DOI: 10.7326/0003-4819-105-5-649. View

15.

Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A . Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005; 174(9):5789-95. DOI: 10.4049/jimmunol.174.9.5789. View

16.

Vaidya A, Forman J . Vitamin D and hypertension: current evidence and future directions. Hypertension. 2010; 56(5):774-9. DOI: 10.1161/HYPERTENSIONAHA.109.140160. View

17.

Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K . Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant. 2010; 25(10):3236-40. DOI: 10.1093/ndt/gfq155. View

18.

Vaidya A, Forman J, Hopkins P, Seely E, Williams J . 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst. 2011; 12(3):311-9. PMC: 3146958. DOI: 10.1177/1470320310391922. View

19.

Yang R, Huang Q, Xu A, McLenithan J, Eisen J, Shuldiner A . Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun. 2003; 310(3):927-35. DOI: 10.1016/j.bbrc.2003.09.093. View

20.

Straburzynska-Lupa A, Nowak A, Pilaczynska-Szczesniak L, Straburzynska-Migaj E, Romanowski W, Karolkiewicz J . Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol. 2010; 28(1):19-24. View